NCT06516055View on ClinicalTrials.gov

Study of S1B-408 in Women With Orgasmic Dysfunction

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

March 30, 2027

Conditions
Orgasmic Disorder
Interventions
DRUG

S1B-408

Medication with multiple monoamine activities

All Listed Sponsors
lead

S1 Biopharma, Inc.

INDUSTRY